MDM2 and liposarcoma: Interestingly, similar effect was observed upon exposure to PARP inhibitor in case of liposarcoma and other tumors, however, upregulation of p21WAF1/CIP1 and proteosomal degradation of MDM2 were accompanied by downregulation of CDK4 [30, 31].